Successful weaning from the invasive respiratory support after nusinersen treatment in a child with SMA type 1: A case report

Overview of attention for article published in Frontiers in Pediatrics, February 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 1 news story.

A late start to treatment with nusinersen can still yield improvements in spinal muscular atrophy (SMA), suggest insights from…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.